Aims: To examine the potential role of the lipolytic enzyme phospholipase A2, produced by Helicobacter pylori in ulcer formation. Methods: Phospholipase A2 activity in H pylori was compared with that in 10 commonly occurring pathogenic bacteria. Phospholipase A2 activity and its cytotoxic metabolite, lysolecithin, in the basal gastric aspirates of 12 patients infected with H pylori were compared with those in 12 subjects not infected with Hpyloni. Results: The phospholipase A2 activity in H pylori was substantially higher than that in most of the other bacteria tested, and the activities of phospholipase A2 and lysolecithin in the basal gastric aspirates of those infected with H pylori were significantly higher than the activities found in the basal gastric aspirates of subjects who were not infected. The lysolecithin proportion of total phospholipids in the gastric aspirates was also much higher in the infected than the non-infected group and a weak positive correlation (0O415) was found between phospholipase A2 and lysolecithin in the infected group. Conclusions: H pylor has clinically important concentrations of phospholipase A2, an enzyme capable of hydrolysing gastric mucosal phospholipids. The high values of phospholipase A2 and lysolecithin in gastric fluid from subjects with H pylori infections supports the notion that phospholipase A2 is involved in the inflammation and mucosal damage associated with peptic ulcer formation.
The pathogenesis of ulcer formation has still not been satisfactorily elucidated despite the increasing acceptance ofthe role ofHelicobacter pylori in duodenal and, to a lesser extent, gastric ulcers.' Hypotheses include impaired mucosal defence by H pylori toxins,2 3 ammonia,4 inflammation5 or hydrogen ion back-diffusion. 6 We suggest another hypothesis that involves the action or metabolites of phospholipase A2 (PLA2) [E.C.3.1.1.4], an enzyme capable of hydrolysing membrane phospholipids, which in the presence of strong gastric acidity, leads to mucosal damage. This study was designed to examine the possible clinical importance of PLA2 activity in gastritis and peptic ulceration.
H pylori, a Gram negative bacterium, has been reported to have PLA2 activity,7 and this has been shown to exist in several other pathogenic bacteria, particularly in the context of a bacterial cause of premature labour. 8 The magnitude of PLA2 activity in the H pylori bacterium was important to this study and the activity in two strains was compared with PLA2 activity in other bacteria to provide a frame of reference. Furthermore, to determine if PLA2 activities were higher in the stomachs of H pylori positive patients than H pylori negative patients, the basal gastric aspirates from both types of patients attending a gastroscopy clinic were analysed for PLA2, total choline phospholipids, and lysolecithin, and the results compared.
Lysolecithin, a cytotoxic, amphipathic lipid produced by the action of PLA2 on phospholipids,9 was measured as an indirect indicator of PLA2 activity. It They were ultrasonicated in an ice bath with a Sonic Dysmembrator (Dynatech; Billingshurst, Kent) using a microprobe, for a total of 3 x 15 seconds at 4°C. After sonication the bacteria were centrifuged at 12 000 rpm for five minutes to remove cell debris. The supernatant cytoplasms or "sonicates" were analysed for protein and PLA2 analysis. Saline washings were prepared by gently washing the H pylori culture plates with a few millilitres of 0-9% physiological saline. The remaining bacteria were removed by centrifugation and the washings assayed as for the sonicates. Analyses were performed in duplicate in three separate analyses. Phospholipase A2, total phospholipid, and lysolecithin activities were assayed in fasting gastric fluid aspirated from the body of the stomach at the beginning of endoscopy, from 12 patients subsequently confirmed by biopsy, culture, and histology to be H pylori positive and 12 patients who were attending a gastroscopy clinic after an overnight fast and no medication on the day of the test, as described previously. " Total protein, used to assess the concentrations of the bacterial supernatants, was assayed by the bicinchoninic acid assay.'2 This has proved more tolerant than the Lowry method to interference, in particular detergents. Phos was 36 (7) Units/gram total protein, which was considerably lower than that found in the total bacterial sonicate. PLA2 activity in the gastric aspirates of the positive patients, 86 7 (45) pmol/min/ml, was significantly higher than in the aspirates of the negative patients, 215 (19) pmol/min/ml (fig   1) , using Student's t test for unrelated data (p < 0 001). The optimal activity of PLA2 in both the gastric fluids and H pylori sonicates was at pH 7-4. Activity was noticeably reduced by about 60% at pH 4 0 and virtually non-existent at pH 2-0.
The group. There was a small overlap between groups on all the parameters measured, reflecting the wide range of values that may be found in gastric aspirates, as noted by Begemann and Schumpelick in assessing gastroduodenal reflux. '6 The correlations between PLA2 activity and the other parameters, total phospholipids and lysolecithin, were close to zero in all cases, except for a positive correlation of 0415 between PLA2 and lysolecithin in Hpylori positive patients.
Discussion
Significant PLA2 activities were found in the cell sonicates of all the pathogenic bacteria examined in this study. The concentrations of PLA2 in the sonicates of the two strains of H pylori were among the highest values found in the other bacteria. This study confirms a previous finding of PLA2 activity in many pathogenic bacteria,8 although Lumb et al found significant PLA2 activity only in E coli and not in Lactobacillus or group B streptococci.'7 Also confirmed is a report indicating high PLA2 activity in eight strains of Hpylori. 7 The protein adjusted PLA2 activity in the saline washings of H pylori was less than half that of the sonicates, but because PLA2s are small molecular weight proteins of 12-18 kilodaltons,'8 this suggests it can diffuse, or be secreted, to the outside of the bacterium in sufficient concentration to hydrolyse membrane phospholipids and initiate the inflammatory process seen in gastritis. The likelihood of PLA2 coming from lysed non-viable Hpylori was reduced by collecting the bacteria at three days of culture and not more. The PLA2 activity outside the cells contradicts the finding of Lumb et al, who tested some pathogenic bacteria (but not H pylorn), and found no spontaneous release of PLA2 into culture media from them. '7 A small significant increase in PLA2 activity was found in the gastric fluid from the Hpylori positive group compared with the negative group, but the values were much lower than those obtained in the Hpylori saline washings. The origin of the gastric fluid PLA2, which is optimised at pH 7-4, is under investigation. It may be released from elsewhere other than H pylori-that is, from the gastric mucosa, or infiltrating white blood cells in the inflamed regions of the stomach. The activity of the PLA2 was found to be very low at the acidic pH expected in the lumen of the stomach, but H pylori, while motile, resides in the proximity of the gastric epithelial surface protected by a thick mucous layer,'9 where the environmental pH is physiological.
The phospholipid and lysolecithin concentrations of the gastric aspirates were also significantly higher in the Hpylori positive group than the negative group. This confirms an earlier study in which lysolecithin was suggested as being a factor in gastric ulceration, long before H pylori was identified as a gastric infection.20 Lysolecithin is normally relatively high in gastric fluid, but in the Hpylori positive patients it represented an average 49% of total phospholipids, while in the H pylori negative patients it was only 19-5% of the total, indicating that significantly more phospholipid hydrolysis had occurred in the Hpylori positive patients.
Increased duodenal reflux of biliary fluid rich in lysolecithin in gastric inflammation has been reported,2' but Schumpelick et al found that such reflux was very moderate in ulcer disease.22 Lysolecithin concentrations in the basal gastric secretion from patients with gastric ulcer, however, have been found to be higher than in patients with duodenal ulcer,23 which militates against gastroduodenal reflux being a major factor causing increased gastric lysolecithin concentrations.
Since 1982, when Warren and Marshall first identified H pylori on gastric epithelium24 and made the connection between the bacterium, gastritis, and ulceration,25 its role has become widely accepted in these conditions. Despite a large amount of information being generated about this organism, as recently reviewed by Buck,29 it is still not known how H pylori is involved in gastric tissue damage. This study has shown that H pylori has significant PLA2 activity, which acts by hydrolysing the fatty acid from the second carbon of membrane phospholipids to release highly cytotoxic lysophospholipids, such as lysolecithin, and fatty acids.27 Lysolecithin is metabolised more slowly than fatty acids, persists in tissues longer, and because of its amphipathic properties is worthy of attention as an ulcer producing agent. It is also a precursor to platelet activating factorn 29 which in studies on rats has been acknowledged as the most powerful ulcerogenic agent so far encountered.'0 The simple approach is that the inflammation and impaired mucosal defence caused by the action of the bacterium creates an environment which, in the presence of strong gastric acidity, leads to ulceration. A more complex mechanism may be involved, however. For example, one of the fatty acids released by PLA2 activity is arachidonic acid from which powerful lipid mediators such as prostaglandins, leucotrienes, and thromboxanes of the "arachidonic acid cascade" are derived,"' and these may contribute directly to tissue damage. Significant PLA2 activities in H pylori and significantly higher concentrations of both PLA2 and lysolecithin in the gastric fluids of H pylori positive compared with Hpylori negative patients suggest that the organism is capable of initiating the inflammatory processes found in gastritis and ulceration, through mechanisms involving lysolecithin and possibly platelet activating factor.
